ROPEOK(SH:688619)2023-08-16 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥10,907,971.17, representing a decrease of 75.58% compared to the same period last year[2]. - The net profit attributable to shareholders was -¥12,740,256.07, a decline of 711.60% year-on-year[2]. - The net cash flow from operating activities was -¥76,015,019.07, indicating a significant cash outflow[2]. - Total operating revenue for Q1 2022 was ¥10,907,971.17, a decrease of 75.5% compared to ¥44,671,575.22 in Q1 2021[15]. - Net loss for Q1 2022 was ¥13,425,828.86, compared to a net profit of ¥1,387,782.55 in Q1 2021, representing a significant decline[16]. - The gross profit margin for Q1 2022 was negative, indicating a challenging cost structure with operating costs exceeding revenues[15]. - Basic and diluted earnings per share for Q1 2022 were both -¥0.07, compared to ¥0.01 in Q1 2021, indicating a shift to losses[16]. - The company experienced a significant increase in credit impairment losses, amounting to ¥4,384,279.81 in Q1 2022, compared to a reversal of losses in Q1 2021[15]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,951,489,421.64, down 7.42% from the end of the previous year[3]. - As of March 31, 2022, the company's total assets amounted to approximately ¥1,951.49 million, a decrease from ¥2,107.93 million as of December 31, 2021, reflecting a decline of about 7.43%[11]. - The company's current assets totaled ¥1,328.62 million, down from ¥1,716.97 million, indicating a decrease of approximately 22.61%[11]. - The total liabilities as of March 31, 2022, were not explicitly stated but included significant short-term borrowings of ¥1 million, down from ¥68.07 million[12]. - The company reported a total liability of ¥576,188,463.56 as of March 31, 2022, down from ¥719,206,250.59 at the end of 2021[13]. - The total liabilities and equity combined were ¥1,951,489,421.64 as of March 31, 2022, down from ¥2,107,933,037.53 at the end of 2021[13]. Cash Flow - The net cash outflow from operating activities was CNY -76,015,019.07, an improvement from CNY -124,813,050.48 in the same period last year[17]. - Total cash outflow from investment activities was CNY 379,411,238.53, down from CNY 447,735,610.85 in Q1 2021, indicating a decrease of 15.3%[18]. - The net cash flow from investment activities was CNY -379,061,998.09, compared to CNY -447,640,860.85 in Q1 2021, showing a reduction of 15.3%[18]. - Cash inflow from financing activities totaled CNY 1,000,000.00, significantly lower than CNY 942,413,817.09 in Q1 2021[18]. - The net cash outflow from financing activities was CNY -67,220,316.66, a substantial decrease from CNY 779,119,333.02 in the previous year[18]. - The ending cash and cash equivalents balance was CNY 254,893,901.18, down from CNY 378,179,211.69 at the end of Q1 2021[18]. Research and Development - Research and development expenses totaled ¥9,823,271.50, accounting for 90.06% of operating revenue, an increase of 72.30 percentage points[3]. - Research and development expenses increased to ¥9,823,271.50 in Q1 2022, up 24% from ¥7,931,640.04 in Q1 2021, reflecting a focus on innovation[15]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 9,974[8]. - Total equity attributable to shareholders was ¥1,364,342,231.24, slightly down from ¥1,377,082,487.31 at the end of 2021[13]. Strategic Focus - The company faced significant revenue and profit reductions due to supply chain instability and order delivery delays caused by the pandemic[6]. - The company is focusing on improving accounts receivable management and enhancing strategic cooperation with suppliers to improve cash flow[6]. - The company has not provided specific guidance or outlook for future performance in the conference call[10]. - The company did not report any new product launches or significant market expansion strategies during this quarter[20].